209 related articles for article (PubMed ID: 19637194)
1. Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth.
Rabenhorst U; Beinoraviciute-Kellner R; Brezniceanu ML; Joos S; Devens F; Lichter P; Rieker RJ; Trojan J; Chung HJ; Levens DL; Zörnig M
Hepatology; 2009 Oct; 50(4):1121-9. PubMed ID: 19637194
[TBL] [Abstract][Full Text] [Related]
2. Fuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.
Dixit U; Liu Z; Pandey AK; Kothari R; Pandey VN
BMC Cancer; 2014 Dec; 14():925. PubMed ID: 25487856
[TBL] [Abstract][Full Text] [Related]
3. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K
Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151
[TBL] [Abstract][Full Text] [Related]
4. FUSE Binding Protein 1 Facilitates Persistent Hepatitis C Virus Replication in Hepatoma Cells by Regulating Tumor Suppressor p53.
Dixit U; Pandey AK; Liu Z; Kumar S; Neiditch MB; Klein KM; Pandey VN
J Virol; 2015 Aug; 89(15):7905-21. PubMed ID: 25995247
[TBL] [Abstract][Full Text] [Related]
5. PI3K/AKT/mTOR-dependent stabilization of oncogenic far-upstream element binding proteins in hepatocellular carcinoma cells.
Samarin J; Laketa V; Malz M; Roessler S; Stein I; Horwitz E; Singer S; Dimou E; Cigliano A; Bissinger M; Falk CS; Chen X; Dooley S; Pikarsky E; Calvisi DF; Schultz C; Schirmacher P; Breuhahn K
Hepatology; 2016 Mar; 63(3):813-26. PubMed ID: 26901106
[TBL] [Abstract][Full Text] [Related]
6. C-Myc-dependent repression of two oncogenic miRNA clusters contributes to triptolide-induced cell death in hepatocellular carcinoma cells.
Li SG; Shi QW; Yuan LY; Qin LP; Wang Y; Miao YQ; Chen Z; Ling CQ; Qin WX
J Exp Clin Cancer Res; 2018 Mar; 37(1):51. PubMed ID: 29523159
[TBL] [Abstract][Full Text] [Related]
7. Far upstream element-binding protein 1 is a prognostic biomarker and promotes nasopharyngeal carcinoma progression.
Liu ZH; Hu JL; Liang JZ; Zhou AJ; Li MZ; Yan SM; Zhang X; Gao S; Chen L; Zhong Q; Zeng MS
Cell Death Dis; 2015 Oct; 6(10):e1920. PubMed ID: 26469968
[TBL] [Abstract][Full Text] [Related]
8. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
[TBL] [Abstract][Full Text] [Related]
9. Dysfunction of IKZF1/MYC/MDIG axis contributes to liver cancer progression through regulating H3K9me3/p21 activity.
Huo Q; Ge C; Tian H; Sun J; Cui M; Li H; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J
Cell Death Dis; 2017 May; 8(5):e2766. PubMed ID: 28471446
[TBL] [Abstract][Full Text] [Related]
10. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
[TBL] [Abstract][Full Text] [Related]
11. Overexpression and role of the ATPase and putative DNA helicase RuvB-like 2 in human hepatocellular carcinoma.
Rousseau B; Ménard L; Haurie V; Taras D; Blanc JF; Moreau-Gaudry F; Metzler P; Hugues M; Boyault S; Lemière S; Canron X; Costet P; Cole M; Balabaud C; Bioulac-Sage P; Zucman-Rossi J; Rosenbaum J
Hepatology; 2007 Oct; 46(4):1108-18. PubMed ID: 17657734
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells.
Malz M; Weber A; Singer S; Riehmer V; Bissinger M; Riener MO; Longerich T; Soll C; Vogel A; Angel P; Schirmacher P; Breuhahn K
Hepatology; 2009 Oct; 50(4):1130-9. PubMed ID: 19585652
[TBL] [Abstract][Full Text] [Related]
13. Ku80 functions as a tumor suppressor in hepatocellular carcinoma by inducing S-phase arrest through a p53-dependent pathway.
Wei S; Xiong M; Zhan DQ; Liang BY; Wang YY; Gutmann DH; Huang ZY; Chen XP
Carcinogenesis; 2012 Mar; 33(3):538-47. PubMed ID: 22226916
[TBL] [Abstract][Full Text] [Related]
14. Loss of FBP1 facilitates aggressive features of hepatocellular carcinoma cells through the Warburg effect.
Yang J; Wang C; Zhao F; Luo X; Qin M; Arunachalam E; Ge Z; Wang N; Deng X; Jin G; Cong W; Qin W
Carcinogenesis; 2017 Feb; 38(2):134-143. PubMed ID: 27742690
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of far upstream element (FUSE) binding protein (FBP)-interacting repressor (FIR) supports growth of hepatocellular carcinoma.
Malz M; Bovet M; Samarin J; Rabenhorst U; Sticht C; Bissinger M; Roessler S; Bermejo JL; Renner M; Calvisi DF; Singer S; Ganzinger M; Weber A; Gretz N; Zörnig M; Schirmacher P; Breuhahn K
Hepatology; 2014 Oct; 60(4):1241-50. PubMed ID: 24824848
[TBL] [Abstract][Full Text] [Related]
16. Colocalization of MID1IP1 and c-Myc is Critically Involved in Liver Cancer Growth via Regulation of Ribosomal Protein L5 and L11 and CNOT2.
Jung JH; Lee HJ; Kim JH; Sim DY; Im E; Kim S; Chang S; Kim SH
Cells; 2020 Apr; 9(4):. PubMed ID: 32316188
[TBL] [Abstract][Full Text] [Related]
17. Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis.
Qi R; An H; Yu Y; Zhang M; Liu S; Xu H; Guo Z; Cheng T; Cao X
Cancer Res; 2003 Dec; 63(23):8323-9. PubMed ID: 14678992
[TBL] [Abstract][Full Text] [Related]
18. USP22 regulates cell proliferation by deubiquitinating the transcriptional regulator FBP1.
Atanassov BS; Dent SY
EMBO Rep; 2011 Sep; 12(9):924-30. PubMed ID: 21779003
[TBL] [Abstract][Full Text] [Related]
19. SPOCK1 is regulated by CHD1L and blocks apoptosis and promotes HCC cell invasiveness and metastasis in mice.
Li Y; Chen L; Chan TH; Liu M; Kong KL; Qiu JL; Li Y; Yuan YF; Guan XY
Gastroenterology; 2013 Jan; 144(1):179-191.e4. PubMed ID: 23022495
[TBL] [Abstract][Full Text] [Related]
20. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
